PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES
Download
Report
Transcript PHILHEALTH CLINICAL PATHWAYS CLINICAL GUIDELINES
PHILHEALTH
CLINICAL PATHWAYS
CLINICAL GUIDELINES
DENGUE CLINICAL PATHWAY
Assessment
Diagnostics
Treatments
Teaching
1st 30 min
2nd 30 min
Ascertained with fever of 2-7
days duration with any of the
following:
skin flushing
rashes
headache
retro-orbital pain
myalgia/arthralgia,
CBC taken
Risk factors for hemorrhagic
tendency assessed.
3rd 30 min
Platelet ct less than 100,000,
do PTT and blood typing
Platelet ct greater than 100,000
discharge and advised to do
serial CBC daily
Admit if:
platelet count is less than
100,000
OR
if with any of the ff. regardless
of the platelet count
spontaneous bleeding
persistent abdominal pain
persistent vomiting
changes in mental status
restlessness
weak rapid pulse
cold clammy skin
circumoral cyanosis
difficulty of breathing
seizures
hypotension
narrowing of pulse
pressure.
Give information on Dengue
fever and measures to control
infection at home
ADMITTING
ORDERS
Admitting Impression: Dengue Fever
Concomitant diagnosis:
____________________________
Please admit to room of choice under the service of Dr. ________________
Diet: __________________________________
Vital signs:
Lab:
–
–
–
–
–
–
–
–
–
every 4 hours
every _____________
CBC
blood typing
PTT
SGPT
Urinalysis
Chest x-ray PA and lateral
Na, K
BUN, Creatinine
Others: __________________________
__________________________
ADMITTING ORDERS
•
IVF:
__________________________
Other medications:
_________________________________________________
_________________________________________________
•
Ancillary Therapy:
_________________________________________________
_________________________________________________
_________________________________________________
•
•
•
Referral to other services:
Hematology _________________________________________________
Others
_________________________________________________
•
•
•
•
•
•
Inform attending physician(s) and resident-on-duty of patient’s room number
Refer for any undue development.
______________________
Signature over printed name
Attending Physician